Products
eSight showcases wearable assistive device for central vision loss
Company’s latest iteration is the eSight GO, designed as a lightweight device incorporating natural peripheral vision for 100% mobility retention.
Business
Gentex acquires eSight to develop next-gen electronic eyewear
Asset acquisition involves a wearable device designed specifically for visually-impaired individuals.
Pipeline
FDA grants SPA for Outlook Therapeutics' NORSE EIGHT AMD trial
The 90-day non-inferiority trial on bevacizumab-vikg would support a potential BLA submission by the end of 2024.
Research
Study suggests ocular history may raise risk for recurrent shingles
Recurrent herpes zoster ophthalmicus clustered in the eight weeks immediately following shingles vaccination, with nearly all cases tied to pre-existing ocular involvement.
Products
FDA issues nationwide voluntary recall for over 3M eye drop bottles
Federal agency identifies eight types of generic eye drops sold under store-brand names connected to potential risk for sterility issues.
Research
First real-world data shows early promise of high-dose aflibercept for wet AMD
Eight-week findings from the SPECTRUM observational study indicate a safety profile consistent with prior evaluations.
Products
Altris AI launches new app for direct OCT syncing
Altris Sync software syncs directly to OCT devices from eight leading manufacturers, enabling automated OCT file uploading and eliminating the need for manual operation.
Business
Global Myopia Awareness Coalition names 2024 Board of Directors
Industry coalition selects eight industry leaders to join its fight against pediatric myopia.
Pipeline
New SightGlass 24-month data shows DOT lenses significantly slow pediatric myopia progression
Unveiled at ARVO 2026, DOT lenses saved more than 1 D of myopic progression on average after 2 years among 6-to-10-year-old wearers.
Business
Leadership watch: Qlaris, VSP, FFB, and SightGlass share updates
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Business
Leadership watch: Prevent Blindness, SightGlass, and Meibum Scientific share updates
Industry changes are underway in the eyecare space—and we’ve got the latest.
Pipeline
SightGlass unveils 18-month data on DOT spectacle lenses for myopia
Latest findings follow 12-month data reported at ARVO; results show over 50% of pediatric patients had no clinically meaningful disease progression.
Products
Sight Sciences debuts OMNI Edge Surgical System
Launching during ASCRS, this new hand-held and single-use MIGS device features the company’s patented, higher-capacity viscoelastic delivery TruSync technology.
Products
EssilorLuxottica's Nuance Audio pairs sight and sound
Nuance Audio combines proprietary software with fashion-forward glasses for a new consumer demographic.
Business
Sightpath Medical now owns LASIK provider PennVista
Provider of mobile ophthalmic services adds all-in-one provider of ophthalmic surgery services to its growing presence across the United States.
Legal
Alcon faces penalty over Sight Sciences patent infringement
Jury trial rules that Alcon willfully infringed on three Sight Sciences patents, compelling them to pay $34 million in monetary damages.
Research
Sight Sciences reports real-world data on leading MIGS devices, including OMNI Surgical System
Large-scale, comparative study also evaluated the Hydrus Microstent and iStent inject for lowering IOP in 100,000+ glaucoma patients’ eyes.
Research
Sight Sciences reports new data from GEMINI extension trial on OMNI Surgical System
Findings build on original 12-month results supporting its efficacy in lowering IOP and medication adherence in OAG.
Products
FDA grants Breakthrough Device Designation to SightGlass Vision's DOT spectacle lenses
Technology is designed to potentially slow myopia progression in pediatric patients aged 6-13.
Products